摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-(tert-butyloxycarbonylamino)-5,7,8,9-tetrahydro-benzocyclohepten-6-one | 1023620-26-9

中文名称
——
中文别名
——
英文名称
7-(tert-butyloxycarbonylamino)-5,7,8,9-tetrahydro-benzocyclohepten-6-one
英文别名
7-(tert-butoxycarbonyl-amino)-5,7,8,9-tetrahydro-benzocyclohepten-6-one;tert-butyl N-(6-oxo-5,7,8,9-tetrahydrobenzo[7]annulen-7-yl)carbamate
7-(tert-butyloxycarbonylamino)-5,7,8,9-tetrahydro-benzocyclohepten-6-one化学式
CAS
1023620-26-9
化学式
C16H21NO3
mdl
——
分子量
275.348
InChiKey
NWEUEAHSGYCXLS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    55.4
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Rapid and efficient synthesis of a novel series of substituted aminobenzosuberone derivatives as potent, selective, non-peptidic neutral aminopeptidase inhibitors
    摘要:
    Racemic 5-substituted 7-aminobenzocyclohepten-6-one were synthesized and evaluated for their ability to inhibit metalloaminopeptidase activities. Unexpectedly, 5-thio substituted compounds showed enhanced inhibition potency with K-i values in the nanomolar range against the 'one zinc' aminopeptidases from the M1 family, while most of them were rather poor inhibitors of the 'two zincs' enzymes from the M17 family. This interesting selectivity profile may guide the design of new, specific inhibitors of target mammalian aminopeptidases with one active site zinc. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.06.041
  • 作为产物:
    描述:
    在 sodium tetrahydroborate 、 cobalt(II) chloride hexahydrate 、 盐酸羟胺 、 sodium carbonate 作用下, 以 吡啶甲醇 为溶剂, 反应 11.0h, 生成 7-(tert-butyloxycarbonylamino)-5,7,8,9-tetrahydro-benzocyclohepten-6-one
    参考文献:
    名称:
    Aminobenzosuberone Scaffold as a Modular Chemical Tool for the Inhibition of Therapeutically Relevant M1 Aminopeptidases
    摘要:
    对于甲基取代的7-氨基-5,7,8,9-四氢苯并环庚烯-6-酮盐酸盐的合成进行了优化,以增强可重复性并提高总产量。为了研究它们的特异性,进行了一系列酶抑制实验,针对多种蛋白酶,包括天冬氨酸蛋白酶、半胱氨酸蛋白酶、金属蛋白酶和丝氨酸内切肽酶的代表性成员,以及单金属M1家族氨基肽酶的八个成员,以及双金属M17和M28氨基肽酶家族的两个成员。这种氨基苯并苏二酮骨架确实表现出对M1氨基肽酶的选择性抑制,而不影响其他测试的蛋白酶家族;它对哺乳动物APN以及其细菌/寄生物同源物EcPepN和PfAM1表现出特别强效。
    DOI:
    10.3390/molecules23102607
点击查看最新优质反应信息

文献信息

  • AMINOBENZOCYCLOHEPTENE DERIVATIVES, METHODS FOR PREPARING THE SAME AND USES THEREOF IN THERAPY
    申请人:Tarnus-Rondeau Céline
    公开号:US20100069504A1
    公开(公告)日:2010-03-18
    A compound of the general formula (I) as an active principle for treating cancer, specifically tumors, in particular diseases involving inhibition of metalloproteases, such as Aminopeptidase-N. Pharmaceutical compositions comprising the compound of general formula (I). Methods of treatment using the compound of general formula (I).
    一种具有一般化学式(I)的化合物作为治疗癌症的活性成分,特别是肿瘤,特别是涉及金属蛋白酶抑制的疾病,如氨基肽酶-N。包括具有一般化学式(I)的化合物的药物组合物。使用一般化学式(I)的化合物进行治疗的方法。
  • Amino-benzosuberone: A novel warhead for selective inhibition of human aminopeptidase-N/CD13
    作者:Sébastien Albrecht、Mira Al-Lakkis-Wehbe、Alban Orsini、Albert Defoin、Patrick Pale、Emmanuel Salomon、Céline Tarnus、Jean-Marc Weibel
    DOI:10.1016/j.bmc.2011.01.008
    日期:2011.2
    This paper describes the design and synthesis of compounds belonging to a novel class of highly selective mammalian CD13 inhibitors. Racemic homologues of 3-amino-2-tetralone 1 were synthesised and evaluated for their ability to selectively inhibit the membrane-bound, zinc-dependent aminopeptidase-N/CD13 (EC 3.4.11.2). Some of these novel non-peptidic compounds are potent, competitive inhibitors of
    本文介绍了属于新型一类高选择性哺乳动物CD13抑制剂的化合物的设计和合成。合成了3-氨基-2-四氢萘酮1的外消旋同源物,并评估了其选择性抑制膜结合的锌依赖性氨基肽酶-N / CD13的能力(EC 3.4.11.2)。这些新颖的非肽类化合物中的某些是哺乳动物酶的有效竞争性抑制剂,尽管其最小尺寸(MW <200 Da),但K i值仍在低微摩尔范围内。而且,它们对氨肽酶家族的代表性成员,即亮氨酸氨肽酶(EC 3.4.11.1),解毒气单胞菌显示出有趣的选择性。氨基肽酶(EC 3.4.11.10)和白三烯A4水解酶的氨基肽酶活性(EC 3.3.2.6)。就效力,稳定性和选择性而言,氨基-苯并亚砜酮衍生物4是最有前途的化合物。根据观察到的结构-活性关系,从已知三维结构的氨基肽酶-N同源物的结构见解,提出了一种假设的4与催化锌和几个保守的活性位点残基的结合模式。
  • DERIVES D'AMINOBENZOCYCLOHEPTENE, LEURS PROCEDES DE PREPARATION ET LEUR UTILISATION EN THERAPEUTIQUE
    申请人:Universite De Haute Alsace
    公开号:EP2084125A1
    公开(公告)日:2009-08-05
  • [EN] AMINOBENZOCYCLOHEPTENE DERIVATIVES, METHODS FOR PREPARING THE SAME AND USES THEREOF IN THERAPY<br/>[FR] DERIVES D' AMINOBENZOCYCLOHEPTENE, LEURS PROCEDES DE PREPARATION ET LEUR UTILISATION EN THERAPEUTIQUE
    申请人:UNIV HAUTE ALSACE
    公开号:WO2008059141A1
    公开(公告)日:2008-05-22
    [EN] The invention relates to a compound of the general formula (I) : F(I) in which: R1, R2, R3, R4, R5, R6, R9, R10, R11 further represent a (C1-C6) alkoxy, (C1-C6) aralkyloxy, (C1-C6) alkylthio, (Q1- C6) aralkylthio radical; R9 et R11 can also form together a carbonated cycle or heterocycle or can form a double bond with the two carbon atoms adjacent to the heptene cycle; R1 et R2 can form together a carbonated cycle or heterocycle; or R1 can be bonded to the heptene cycle by a double bond while R2 is absent; R3, R4, R5 and R6 further represent a polyfluoro (C1-C6) alkyl, (C1-C6) alkoxy radical, an aryl or heteroaryl group; R3 and R4, R4 and R5, R5 and R6 can further form together a methylenedioxy radical joining the adjacent carbon atoms or an aromatic carbonated cycle or an aromatic heterocycle; R7 is a hydrogen atom, a (C1-C6) alkyl radical; X is an oxygen or sulphur atom, N-R12, N-O-R13, in which R12 and R13 represent a hydrogen atom, a (C1-C6) alkyl, (C1- C6) (cycloalkyl) alkyl, (C1-C6) (heterocycloalkyl) alkyl, (C1-C6) aralkyl, (Ci-C6) heteroaralkyl radical; Y is a carbon atom; a nitrogen atom R8 or R9 being then absent; the invention also relates to addition salts with acids except the compound for which R4, R5, R6 represent a methoxy radical, R1, R2, R3, R7 to R11 represent a hydrogen atom, X represents an oxygen atom and Y represents a carbon atom.
    [FR] Composé répondant à la formule générale (I): F(I) dans laquelle R1, R2, R3, R4, R5, R6, R9, R10, R11 représentent en outre un radical (C1-C6) alcoxy, (C1-C6) aralkyloxy, (C1-C6) al kylthio, (Q1- C6) aralkylthio; R9 et R11
  • Rapid and efficient synthesis of a novel series of substituted aminobenzosuberone derivatives as potent, selective, non-peptidic neutral aminopeptidase inhibitors
    作者:Sébastien Albrecht、Emmanuel Salomon、Albert Defoin、Céline Tarnus
    DOI:10.1016/j.bmc.2012.06.041
    日期:2012.8
    Racemic 5-substituted 7-aminobenzocyclohepten-6-one were synthesized and evaluated for their ability to inhibit metalloaminopeptidase activities. Unexpectedly, 5-thio substituted compounds showed enhanced inhibition potency with K-i values in the nanomolar range against the 'one zinc' aminopeptidases from the M1 family, while most of them were rather poor inhibitors of the 'two zincs' enzymes from the M17 family. This interesting selectivity profile may guide the design of new, specific inhibitors of target mammalian aminopeptidases with one active site zinc. (C) 2012 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

2,9-二(2-苯乙基)蒽并[2,1,9-DEF:6,5,10-D’E’F’]二异喹啉-1,3,8,10(2H,9H)-四酮 (βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 (S)-盐酸沙丁胺醇 (S)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-3,3''-双([[1,1''-联苯]-4-基)-[1,1''-联萘]-2,2''-二醇 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,5R)-3,3a,8,8a-四氢茚并[1,2-d]-1,2,3-氧杂噻唑-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aS,8aR)-2-(吡啶-2-基)-8,8a-二氢-3aH-茚并[1,2-d]恶唑 (3aS,3''aS,8aR,8''aR)-2,2''-环戊二烯双[3a,8a-二氢-8H-茚并[1,2-d]恶唑] (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3S,3aR)-2-(3-氯-4-氰基苯基)-3-环戊基-3,3a,4,5-四氢-2H-苯并[g]吲唑-7-羧酸 (3R,3’’R,4S,4’’S,11bS,11’’bS)-(+)-4,4’’-二叔丁基-4,4’’,5,5’’-四氢-3,3’’-联-3H-二萘酚[2,1-c:1’’,2’’-e]膦(S)-BINAPINE (3-三苯基甲氨基甲基)吡啶 (3-[(E)-1-氰基-2-乙氧基-2-hydroxyethenyl]-1-氧代-1H-茚-2-甲酰胺) (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,4S)-Fmoc-4-三氟甲基吡咯烷-2-羧酸 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-硝基苯基)磷酸三酰胺 (2-氯-6-羟基苯基)硼酸 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1α,1'R,4β)-4-甲氧基-5''-甲基-6'-[5-(1-丙炔基-1)-3-吡啶基]双螺[环己烷-1,2'-[2H]indene (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1R,1′R,2S,2′S)-2,2′-二叔丁基-2,3,2′,3′-四氢-1H,1′H-(1,1′)二异磷哚